The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
miR-503-5p induces doxorubicin resistance in triple-negative breast cancer.
 
Iris Garrido-Cano
No Relationships to Disclose
 
Anna Adam-Artigues
No Relationships to Disclose
 
Ana Lameirinhas
No Relationships to Disclose
 
Birlipta Pattanayak
No Relationships to Disclose
 
Eduardo Tormo
No Relationships to Disclose
 
Vera Mónica Miranda-Gonçalves
No Relationships to Disclose
 
Catarina Macedo-Silva
No Relationships to Disclose
 
Federico Rojo
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Incyte; Lilly; Merck; MSD; Novartis; Pfizer; Roche
 
Sandra Zazo
No Relationships to Disclose
 
Juan Madoz-Gúrpide
No Relationships to Disclose
 
Octavio Burgues
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Cristina Hernando
No Relationships to Disclose
 
Maite Martínez
No Relationships to Disclose
 
Santi Moragón
No Relationships to Disclose
 
Begoña Bermejo De Las Heras
Consulting or Advisory Role - MSD; Novartis; Roche
 
Ana Lluch
Consulting or Advisory Role - Celgene; Eisai; Novartis; Pfizer; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Eisai; GlaxoSmithKline; Merck; Novartis; Pfizer; Pfizer; PharmaMar; Pierre Fabre; Roche/Genentech
 
Carmen Jerónimo
No Relationships to Disclose
 
Pilar Eroles
No Relationships to Disclose
 
Juan Miguel Cejalvo
No Relationships to Disclose